Loading...
Market
How many new partnerships will 23andMe announce in 2025?
2
Resolution / Starting Odds
0 • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
23andMe's press releases or industry news outlets
Story
23andMe Cuts 40% of Workforce, Ends Drug Development
Nov 12, 2024, 12:08 AM
23andMe, a genetic testing firm, has announced a significant restructuring program that includes reducing its workforce by approximately 40%, affecting over 200 employees, and discontinuing its drug development efforts. The company aims to streamline operations, reduce costs, and focus on its consumer genetics business. This restructuring will incur one-time costs of up to $12 million.
View original story
Similar markets
Less than 300 • 25%
300 to 500 • 25%
501 to 700 • 25%
More than 700 • 25%
0 • 25%
1 • 25%
2-3 • 25%
4 or more • 25%
0-2 • 25%
3-5 • 25%
6-8 • 25%
More than 8 • 25%
Ancestry services • 25%
Health-related genetics services • 25%
Personalized wellness products • 25%
Other • 25%
Genetic Testing • 25%
Health and Wellness • 25%
Data Licensing • 25%
Other • 25%
0-2 partnerships • 25%
3-5 partnerships • 25%
6-8 partnerships • 25%
More than 8 partnerships • 25%
0 new partnerships • 25%
1-2 new partnerships • 25%
3-4 new partnerships • 25%
5 or more new partnerships • 25%